Skip to main content

You are here

Paragon Bioservices

Paragon Bioservices

Tenant Introduction

Founded in 1990, Paragon Bioservices is a contract research and manufacturing organization whose focus is the production of reagent-grade proteins and biopharmaceuticals for clinical use. Areas of expertise include: therapeutic proteins, monoclonal antibodies, vaccines, viral vectors and bacteriophage. The cGMP manufacturing space includes microbial and mammalian suites, fill-finish, and fully-segregated virus/BSL-3 facilities.

Paragon is a preferred vendor for many of the leading global pharmaceutical companies and currently has multiple ongoing contracts for the US government. Paragon’s goal is to offer integrated capabilities (from research to process development to GMP manufacturing) in order to accelerate their clients’ timeline from research bench to clinical utilization.

Tenant Location

Paragon Bioservices is located in the Wexford Knowledge Community in Baltimore in UMB II of the University of Maryland BioPark. It occupies a total of 53,000 square feet (the entire fourth floor—as well as space on the third and fifth floors).

History of Success

Paragon has received the “CMO Leadership Awards” for Quality and Reliability for three consecutive years from Life Science Leader magazine. This award is based on surveys received from over 10,000 mid-level pharmaceutical executives. In addition, Paragon has received the “Global Supplier Award” from Eli Lilly and their Elanco Animal Health division—as well as Pfizer’s “External Research Award”. Paragon currently has multiple on-going government contracts (US Army, NIH and the Department of Defense).

As Paragon moved into GMP Manufacturing, won government biodefense contracts and developed a Virus Facility and BSL-3 labs, they were able to collaborate with the world-renowned Dr. Myron Levine at the Center for Vaccine Development.

In 2011, Paragon also had the opportunity to work with Dr. Curt Civin—a pioneer in cancer research and stem cell transplantation—at the University of Maryland’s Center for Stem Cell Biology and Regenerative Medicine. Together with Paragon, the university developed a Stem Cell Technology Consortium.

Both Wexford and the executives at the BioPark have been extremely helpful and supportive over the past four years. We could have never gotten this far without their support and generosity.”

“The BioPark offered many unique services and amenities for Paragon’s employees - such as a gym, a café for lunches, The Smith School of Business (for employees who were working on their MBA’s or interested in continuing education).”

Contact Information

Marco A. Chacón, Ph.D.
President and CEO
Paragon Bioservices, Inc.
(410) 975-4050
Visit Website